🔗 Share this article Texas Top Legal Officer Sues Acetaminophen Producers Regarding Autism Spectrum Allegations Ken Paxton, a Trump ally who is running for US Senate, alleged pharmaceutical manufacturers of withholding the risks of Tylenol The top legal official in Texas Ken Paxton is taking legal action against the makers of acetaminophen, asserting the corporations hid safety concerns that the pain reliever presented to children's neurological development. The court filing follows four weeks after Donald Trump advocated an unverified association between using acetaminophen - also known as paracetamol - throughout gestation and autism spectrum disorder in young ones. Paxton is filing suit against J&J, which formerly manufactured the drug, the only pain reliever suggested for expectant mothers, and the current manufacturer, which currently produces it. In a declaration, he claimed they "betrayed America by gaining financially from suffering and pushing pills without regard for the dangers." Kenvue states there is no credible evidence linking acetaminophen to autism spectrum disorder. "These companies misled for generations, knowingly endangering numerous people to increase profits," Paxton, from the Republican party, said. The company commented that it was "deeply concerned by the dissemination of inaccurate information on the reliability of paracetamol and the likely effects that could have on the health of US mothers and children." On its online platform, Kenvue also said it had "continuously evaluated the pertinent research and there is insufficient valid information that shows a verified association between consuming acetaminophen and autism." Organizations representing doctors and health professionals agree. The American College of Obstetricians and Gynecologists has declared paracetamol - the primary component in acetaminophen - is among limited choices for expectant mothers to manage pain and elevated temperature, which can present serious health risks if left untreated. "In over twenty years of studies on the utilization of acetaminophen in pregnancy, zero credible investigations has definitively established that the usage of acetaminophen in any period of gestation results in neurodevelopmental disorders in children," the organization commented. This legal action references current declarations from the former administration in claiming the medication is reportedly hazardous. In recent weeks, the former president caused concern from public health officials when he advised expectant mothers to "resist strongly" not to consume Tylenol when unwell. Federal regulators then released a statement that doctors should consider limiting the use of acetaminophen, while also stating that "a proven link" between the medication and autism spectrum disorder in children has not been proven. Health Secretary RFK Jr, who oversees the FDA, had pledged in April to conduct "comprehensive study program" that would determine the source of autism spectrum disorder in a short period. But authorities warned that finding a sole reason of autism - thought by researchers to be the outcome of a complex mix of genetic and environmental factors - would prove challenging. Autism is a type of enduring cognitive variation and impairment that impacts how persons encounter and engage with the environment, and is recognized using physician assessments. In his legal document, Paxton - aligned with the former president who is campaigning for federal office - claims Kenvue and J&J "intentionally overlooked and sought to suppress the science" around paracetamol and autism. The lawsuit attempts to require the companies "remove any marketing or advertising" that claims acetaminophen is safe for pregnant women. The court case echoes the concerns of a assembly of parents of young ones with autism and ADHD who took legal action against the producers of acetaminophen in two years ago. A federal judge rejected the lawsuit, saying studies from the family's specialists was lacking definitive proof.